JYNT
Joint Corp
$
11.010
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
11.120
Open
11.070
VWAP
11.03
Vol
65.13K
Mkt Cap
168.93M
Low
10.750
Amount
718.37K
EV/EBITDA(TTM)
--
Total Shares
14.97M
EV
139.14M
EV/OCF(TTM)
29.32
P/S(TTM)
9.12
The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
13.36M
-55.76%
--
--
15.11M
-52.73%
--
--
14.85M
+13.54%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for The Joint Corp. (JYNT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 10.32%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+10.32%
In Past 3 Month
4 Analyst Rating
40.78% Upside
Wall Street analysts forecast JYNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JYNT is 15.50 USD with a low forecast of 15.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy
40.78% Upside
Current: 11.010
Low
15.00
Averages
15.50
High
16.00
40.78% Upside
Current: 11.010
Low
15.00
Averages
15.50
High
16.00
Lake Street
Ryan Meyers
Buy
downgrade
$20 -> $16
2025-05-09
Reason
Lake Street
Ryan Meyers
Price Target
$20 -> $16
2025-05-09
downgrade
Buy
Reason
Lake Street analyst Ryan Meyers lowered the firm's price target on Joint Corp. to $16 from $20 and keeps a Buy rating on the shares. The firm believes The Joint continues to make positive strides in its corporate clinic transition following its first quarter 2025 results, but is trimming its price target based on a lower 2026 EBITDA estimate.
Roth MKM
George Kelly
Strong Buy
Maintains
$16 → $15
2024-11-08
Reason
Roth MKM
George Kelly
Price Target
$16 → $15
2024-11-08
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Joint Corp (JYNT.O) is 21.94, compared to its 5-year average forward P/E of 116.51. For a more detailed relative valuation and DCF analysis to assess Joint Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
116.51
Current PE
21.94
Overvalued PE
211.81
Undervalued PE
21.21
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
29.63
Current EV/EBITDA
12.84
Overvalued EV/EBITDA
52.80
Undervalued EV/EBITDA
6.47
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
4.18
Current PS
2.84
Overvalued PS
8.10
Undervalued PS
0.26
Financials
Annual
Quarterly
FY2025Q1
YoY :
+7.33%
13.08M
Total Revenue
FY2025Q1
YoY :
+58.70%
-676.56K
Operating Profit
FY2025Q1
YoY :
+26.85%
-506.02K
Net Income after Tax
FY2025Q1
YoY :
-16.67%
0.05
EPS - Diluted
FY2025Q1
YoY :
-266.94%
-4.03M
Free Cash Flow
FY2025Q1
YoY :
-0.79%
74.51
Gross Profit Margin - %
FY2025Q1
3.38
FCF Margin - %
FY2025Q1
YoY :
+18.35%
-3.87
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
JYNT News & Events
Events Timeline
2025-08-07 (ET)
2025-08-07
16:29:26
Joint Corp. reports Q2 EPS 1c, consensus (2c)
2025-08-07
16:25:34
Joint Corp. lowers 2025 system-wide sales outlook to $530M-$550M
2025-07-07 (ET)
2025-07-07
07:22:25
Joint Corp. closes sale of 31 corporate clinics in Arizona, New Mexico
Sign Up For More Events
Sign Up For More Events
News
9.5
08-10Yahoo FinanceJoint Second Quarter 2025 Earnings: EPS Beats Expectations
9.5
07-31NASDAQ.COMCigna (CI) Surpasses Q2 Earnings and Revenue Estimates
9.5
07-30NewsfilterThe Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges
Sign Up For More News
People Also Watch
BEEP
Mobile Infrastructure Corp
3.730
USD
-1.06%
SCPH
scPharmaceuticals Inc
4.780
USD
-0.42%
NKTR
Nektar Therapeutics
25.720
USD
+8.98%
MHH
Mastech Digital Inc
7.550
USD
+3.57%
LXEO
Lexeo Therapeutics Inc
4.720
USD
+1.07%
BDSX
Biodesix Inc
0.384
USD
-6.57%
NEGG
Newegg Commerce Inc
91.890
USD
+24.78%
STRO
Sutro Biopharma Inc
0.772
USD
-1.53%
ALEC
Alector Inc
2.180
USD
+9.00%
FAQ
What is Joint Corp (JYNT) stock price today?
The current price of JYNT is 11.01 USD — it has decreased -0.63 % in the last trading day.
What is Joint Corp (JYNT)'s business?
What is the price predicton of JYNT Stock?
What is Joint Corp (JYNT)'s revenue for the last quarter?
What is Joint Corp (JYNT)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Joint Corp (JYNT)'s fundamentals?
How many employees does Joint Corp (JYNT). have?